GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. GSK is committed to maximising patient survival through transformational medicines, with a current focus on breakthroughs in immuno-oncology and tumour-cell targeting therapies, and development in haematologic malignancies, gynaecologic cancers and other solid tumours.